Re-Mission

From Wikipedia, the free encyclopedia

Re-Mission

Developer(s)	Realtime Associates, Inc.
Publisher(s)	HopeLab
Release date(s)	April 3, 2006
Genre(s)	Third-person shooters, Serious games
Mode(s)	Single player, multiplayer
Rating(s)	ESRB: Teen(T)
Platform(s)	Windows
Media	CD(4) or DVD(1)
System requirements	1.4GHz CPU, 256MB RAM, 100MB hard disk space (DVD only; 4GB for CD), Direct3D video card w/64MB VRAM, DirectX 9.0c, DirectX compatible sound card
Input	Keyboard, mouse, joystick

Re-Mission is a third-person shooter video game released by the non-profit organization HopeLab on April 3, 2006. The game falls primarily within the serious games genre, is intended to be both informative and entertaining, and is designed for young persons with cancer. The game was the culmination of years of research to ensure that it addressed realistic cancer-related medical issues within the context of entertaining gameplay. A scientific study^[1] involving 375 cancer patients has shown that Re-Mission has a beneficial impact on the health of cancer patients who play the game.

In Re-Mission, the player controls an RX5-E ("Roxxi") nanobot who is designed to be injected into the human body and fight particular types of cancer and related infections at a cellular level. The player must also monitor patient health and report any symptoms back to Dr. West (the in-game doctor and project leader). Each of the 20 levels is designed to inform the patient on a variety of treatments, how they function, and the importance of maintaining strict adherence to those treatments.

Re-Mission is available at no charge to young people with cancer and oncology centers by visiting the game's official website.